Controlled Release for Nutraceuticals: Trends, Technologies, and Innovations from Vitafoods 2026

Controlled release has become a central formulation category in the nutraceutical industry in 2026, spanning delayed-release capsules, enteric coatings, multi-layer beadlets, liposomal and phytosome systems, sustained-release matrices, colon-targeted platforms, and emerging approaches such as dual encapsulation and 3D-printed dosage forms.

At Vitafoods Europe 2026 more than 18 exhibitors presented controlled-release technologies, and delivery innovation featured across several Vitafoods Innovation Award categories. Four forces are driving the acceleration: mainstream probiotics that need gastric protection, GLP-1 companion nutrition that demands precise nutrient timing, the EU titanium dioxide ban that has forced coating reformulation, and B2B demand for alternative formats such as high-dose gummies and personalised supplements.

This article reviews what changed in controlled-release nutraceuticals in 2026, and the technologies, suppliers, and formulation approaches that formulators, procurement teams, and regulatory professionals should evaluate.

Table of Contents

• What Is Controlled Release in Nutraceutical Formulation?
• What Has Changed in 2026: Five Key Shifts
• Delayed-Release Capsules: The Foundation Technology
• Multi-Layer Beadlets and Precision Microencapsulation
• Enteric and Functional Coatings
• Liposomal and Lipid-Based Delivery Systems
• Colon-Targeted Delivery for Microbiome Ingredients
• Sustained-Release Matrix Systems
• Emerging Platforms: Dual Encapsulation and 3D-Printed Dosage Forms
• Technologies That Stood Out at Vitafoods Europe 2026
• Comparison Table: Controlled-Release Technologies for Nutraceutical Formulation
• Regulatory Considerations for Controlled-Release Formats
• FAQs
• Key Takeaways
• Sources

What Is Controlled Release in Nutraceutical Formulation?

Controlled release is any delivery mechanism that modifies the rate, timing, or location at which an active ingredient is released after ingestion, compared with a conventional immediate-release tablet or capsule. In nutraceuticals it serves four objectives: protecting acid-sensitive ingredients (such as probiotics and enzymes) from gastric degradation, targeting a specific segment of the gastrointestinal tract such as the colon, sustaining delivery over several hours, and improving the oral bioavailability of poorly soluble compounds such as curcumin, CoQ10, and fat-soluble vitamins.[1] Technologies range from established platforms (HPMC delayed-release capsules, enteric coatings) to newer approaches such as multi-layer beadlets, liposomal encapsulation, and phytosome complexes.

What Has Changed in 2026: Five Key Shifts

Five developments have reshaped the controlled-release landscape for supplement formulators in 2026.

1. Colon-targeted delivery enters the mainstream. dsm-firmenich’s Microbiome Targeted Technology (MTT), launched as Humiome B2, delivers approximately 90% of vitamin B2 to the colon via a dual coating, moving colon targeting beyond probiotics into vitamin delivery.[2]

2. Multi-layer beadlets enable timed release over 8-12 hours. Specnova’s NovaQSpheres use at least four layers of active ingredient within a polymer-and-cyclodextrin sphere for pH-responsive, precision-timed release.[3]

3. Liposomal platforms now co-load multiple actives. Natural Field’s NFco-Loading platform encapsulates several ingredients within a single liposomal system, such as CoQ10 with NMN.[4]

4. 3D printing approaches commercial scale. ACG’s Personalised Capsule Machine coats capsules formulated on demand from real-time health data, with deployment planned across Europe.[5]

5. The EU titanium dioxide ban drives coating innovation. With E171 banned in EU food and supplements since August 2022, Roquette, Biogrund, JRS Pharma and other coating suppliers have developed plant-based white coatings that retain both appearance and controlled-release function.

See our Infographic on The Science of Precision Delivery:

Delayed-Release Capsules: The Foundation Technology

Delayed-release HPMC capsules remain the most widely adopted controlled-release format, owing to their simplicity, regulatory acceptance, and compatibility with existing filling equipment. Lonza Capsugel’s DRcaps delay release by approximately 45 minutes versus standard gelatin capsules, protecting acid-sensitive ingredients without enteric coatings, while the DUOCAP system places one capsule inside another for dual-release profiles from a single unit.  Lonza also presented Plantcaps, a pullulan-based plant capsule for powder and liquid fills.[7] Roquette‘s Nutra’V HPMC capsules now include TiO2-free formulations using a newly validated opacifying system, alongside tuned HPMC and microcrystalline cellulose systems for controlled or immediate release and ReadiLYCOAT film coating.[8]

Multi-Layer Beadlets and Precision Microencapsulation

Specnova’s NovaQSpheres represent a new category of controlled-release beadlet: each sphere contains at least four layers of active ingredient within a membrane of polymers and cyclodextrins, achieving pH-responsive release with customisable burst-then-sustained or gradual profiles over 8-12 hours. The first commercial product, BodyTech Elite Creatine Beadlets, launched in January 2025 at The Vitamin Shoppe, and the platform suits vitamins, minerals, botanicals, amino acids, and peptides.[3] Microencapsulation has also solved high-dose gummy dosing: TopGum’s TopCap technology delivers 1.5 g of creatine monohydrate (Creapure) or 100 mg of electrolytes per gummy on a clean-label, prebiotic-fibre base,[9] and Mingchyi Biotechnology’s CreHytine, a 2026 Vitafoods Europe sports-nutrition finalist, uses a dual-mechanism acacia-gum-and-magnesium hydrogel to improve creatine’s gastric stability and dissolution.[10]

Enteric and Functional Coatings

Evonik’s EUDRAGUARD portfolio offers food-grade polymer coatings for three targets: protect (gastric protection for acid-sensitive ingredients), biotic (a methyl methacrylate copolymer for colonic delivery at low processing temperatures that preserve probiotics and prebiotics), and natural (moisture protection for hygroscopic ingredients), building on Evonik’s 60-year EUDRAGIT pharmaceutical-polymer track record.[11] The EU titanium dioxide (E171) ban, in effect since August 2022, has driven industry-wide reformulation: Biogrund and Seprify presented a plant-based coating that replaces titanium dioxide with SilvaAlba, a cellulose-based whitener,[6] while Colorcon’s Nutrateric delayed-release system and Opadry NutraPure, the first USDA-certified organic aqueous clear coating for supplements, add further TiO2-free options.[12]

Liposomal and Lipid-Based Delivery Systems

EffePharm’s LipoAvail platform uses phospholipid bilayers that mimic intestinal cell membranes to enhance absorption of both hydrophilic and lipophilic actives. It presented liposomal NAD+ and glutathione.[13] Natural Field’s NFco-Loading platform co-loads multiple actives within a single liposomal system, with NF TriSolve combining CoQ10 and NMN liposomes with ergothioneine and sialic acid for synergistic healthy-aging formulations.[4] Indena’s Phytosome technology disperses botanical extracts into a food-grade soy lecithin matrix that acts as a wetting agent and anti-aggregation inhibitor; its 2026 line included Centextra (Centella), Quercefit (quercetin), and Ubiqsome (CoQ10), alongside Berbevis and Siliphos, spanning polyphenols, terpenes, and saponins.[14]

Have a look at our Introduction to Lipids and Essential Fatty Acids as Supported Nutrients in Nutraceuticals:

Colon-Targeted Delivery for Microbiome Ingredients

Colon-targeted delivery, driven by the growth of probiotic, prebiotic, and postbiotic formulations, goes beyond standard gastric protection (which releases cargo in the upper small intestine) to ensure release specifically in the lower intestine, where the gut microbiota concentrate. dsm-firmenich’s MTT pairs an outer layer that withstands gastric acid and digestive enzymes with an inner layer that dissolves in colonic conditions; its first application, Humiome B2, delivers approximately 90% of vitamin B2 to the colon and was a 2026 Innovation Awards finalist in the Immune and Gut Health category.[2] Evonik’s EUDRAGUARD biotic offers an alternative using pH-independent polymethacrylate microparticles that remain intact in gastric conditions and release in the colon.[11]

Read more on postbiotics here:

Postbiotics: Definition, Clinical Evidence, and Formulation Guide

Sustained-Release Matrix Systems

Sustained-release matrices extend nutrient delivery over several hours by embedding active ingredients in a polymer that gradually erodes or hydrates during gastrointestinal transit. Lubrizol’s Carbopol polymers received EU food-grade approval from the European Commission for liquid and solid supplements, providing stable sustained release, taste masking, and tablet-size reduction by crossing over from pharmaceutical applications.[15] Ashland’s Benecel HPMC grades (K250, K750, K1500 PH PRM) offer intermediate-molecular-weight options for predictable controlled-release matrix tablets, addressing the batch blending variability seen with legacy HPMC formulations.[16]

Emerging Platforms: Dual Encapsulation and 3D-Printed Dosage Forms

EVANIUM, a German startup, has developed Optisolv, a dual encapsulation system pairing a cyclodextrin-based core with a phospholipid outer shell to produce a crystal-free, highly dispersible state that improves solubility, absorption, and taste; the company holds four patents, raised EUR 2.2 million in seed funding, and was a 2026 Startup Challenge finalist (Optisolv Berberine, Boswellia, Passiflora).[17] In 3D printing, Nourished (UK) prints personalised 7-layer nutrient gummy stacks from health-questionnaire data, with suppliers including ADM,[18] Craft Health (Singapore) offers the CraftMake 3D printer and CraftBlends materials for individually customisable controlled-release profiles, and ACG’s Personalised Capsule Machine coats capsules formulated on demand, with over 1,500 machines planned for European deployment.[5]

Technologies That Stood Out at Vitafoods Europe 2026

Delivery-Relevant Innovation Award Finalists

Table 1: Vitafoods Europe 2026 Innovation Award Finalists with Delivery Technology Relevance

 

Key Exhibitors in Controlled Release

Lonza Capsugel showed DRcaps, DUOCAP, Beadlets, and Plantcaps; Roquette presented TiO2-free Nutra’V HPMC capsules; Balchem launched VitaCholine Pro-Flo, the first microencapsulated choline format, in Europe;[20] EffePharm demonstrated LipoAvail; Vantage Nutrition exhibited multi-phase beadlet manufacturing; Glatt showed fluidised- and spouted-bed microencapsulation; and Lubrizol showcased Curcushine, a microencapsulated curcumin gummy, with its Carbopol portfolio.

Comparison Table: Controlled-Release Technologies for Nutraceutical Formulation

Table 2: Controlled-Release Technology Comparison for Nutraceutical Formulators

Regulatory Considerations for Controlled-Release Formats

No specific FDA or EFSA guidance targets controlled-release supplement formats as a distinct regulatory category; the standard dietary-supplement frameworks apply regardless of the delivery technology used.

United States (FDA). The FDA’s 2026 priorities include finalising New Dietary Ingredient (NDI) guidance, GRAS reform, and dietary supplement oversight modernisation. An NDI notification is required 75 days before marketing any supplement containing a new dietary ingredient, regardless of format; the controlled-release excipient or coating itself is not typically the subject of NDI notification, provided it has GRAS status or an established history of safe use in food.[20]

European Union (EFSA). EFSA’s Particle-TR guidance now requires nano-specific assessment for nanoparticle-based delivery systems, directly affecting liposomal, nanoencapsulated, and nanoparticle-based platforms; applicants must determine whether conventional or nano-specific assessment applies and demonstrate analytical methods fit for detecting and characterising small particles.[21] The EU ban on titanium dioxide (E171) continues to drive coating reformulation, while titanium dioxide remains permitted in EU pharmaceuticals.

FAQs

What is controlled release in nutraceutical supplements? Controlled release refers to delivery mechanisms that modify the rate, timing, or location of ingredient release after ingestion. Technologies include delayed-release capsules, enteric coatings, multi-layer beadlets, liposomal encapsulation, sustained-release matrices, and colon-targeted systems. The objective is to protect sensitive ingredients, target specific intestinal regions, or sustain nutrient levels over time.

How does colon-targeted delivery differ from standard enteric coating? Standard enteric coatings protect ingredients from stomach acid and release in the upper small intestine at pH >5.5. Colon-targeted delivery releases specifically in the lower intestine or colon at pH >7.0 or through pH-independent mechanisms. This matters for microbiome-active ingredients that must reach the colon intact, such as those in dsm-firmenich’s Humiome MTT platform.

What is the advantage of multi-layer beadlet technology over conventional microencapsulation? Multi-layer beadlets such as Specnova’s NovaQSpheres use four or more layers of active ingredient within a polymer-and-cyclodextrin membrane to achieve precision-timed, pH-responsive release over 8-12 hours. Conventional microencapsulation typically provides basic moisture or taste-masking protection with limited control over release timing or location.

Can high-dose actives be delivered in gummy formats using controlled-release technology? Yes. Microencapsulation has enabled clinically relevant doses in gummies. TopGum’s TopCap technology delivers 1.5 g of creatine monohydrate per single gummy, and Mingchyi’s CreHytine uses hydrogel encapsulation to stabilise creatine in gummy matrices, addressing the gastric-stability and dissolution challenges that previously limited gummy dosing.

What are liposomal supplements, and how do they enhance bioavailability? Liposomal supplements encapsulate active ingredients within phospholipid bilayers that mimic cell membranes, protecting ingredients during digestion and facilitating absorption by fusing with intestinal cell membranes. They are particularly effective for poorly water-soluble compounds, and co-loading platforms now allow multiple actives in a single liposomal system.

Key Takeaways

Controlled release for nutraceuticals expanded in 2026 from delayed-release capsules and enteric coatings into colon-targeted systems, multi-layer beadlets, co-loaded liposomal platforms, and 3D-printed personalised formats.

Colon-targeted delivery is no longer limited to probiotics: dsm-firmenich’s Humiome MTT delivers approximately 90% of vitamin B2 to the colon to support microbiome metabolism.

Specnova’s NovaQSpheres achieve precision-timed release over 8-12 hours, and microencapsulation has solved high-dose gummy dosing (TopGum delivers 1.5 g creatine per gummy).

The EU titanium dioxide ban continues to drive coating reformulation, with plant-based alternatives from Roquette, Biogrund/Seprify, and Colorcon now commercially available.

EFSA’s Particle-TR guidance introduces nano-specific assessment requirements that directly affect liposomal and nanoencapsulated supplement products in the European market.

Sources

1. “Emerging Encapsulation Techniques for Nutraceuticals.” Frontiers in Nutrition, 2026. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1826702/full (accessed 2026-06-01).
2. “dsm-firmenich’s Humiome Technology Allows Targeted Delivery for Microbiome-Boosting Vitamin B2.” NutraIngredients, March 6, 2025. https://www.nutraingredients.com/Article/2025/03/06/dsm-firmenichs-humiome-technology-allows-targeted-delivery-for-microbiome-boosting-vitamin-b2/ (accessed 2026-06-01).
3. “Specnova Launches NovaQSpheres Controlled-Release Beadlet Technology.” Nutraceuticals World, 2025. https://www.nutraceuticalsworld.com/breaking-news/specnova-launches-novaqspheres-controlled-release-beadlet-technology/ (accessed 2026-06-01).
4. “Natural Field Unveils NFco-Loading Healthy Aging Innovation at Vitafoods Europe 2026.” PR Newswire, May 2026. https://www.prnewswire.com/news-releases/natural-field-unveils-nfco-loading-healthy-aging-innovation-at-vitafoods-europe-2026-302770658.html (accessed 2026-06-01).
5. “ACG Personalised Capsule Manufacturing Technology.” Nutraceutical Business Review, 2026. https://nutraceuticalbusinessreview.com/acg-personalised-capsule-manufacturing-technology (accessed 2026-06-01).
6. “Seprify and Biogrund Develop Titanium Dioxide-Free Tablet Coating for Nutraceuticals.” Food Processing, 2026. https://www.foodprocessing.com.au/content/ingredients/news/seprify-and-biogrund-develop-titanium-dioxide-free-tablet-coating-for-nutraceuticals-947533521 (accessed 2026-06-01).
7. Lonza Capsugel. “DRcaps HPMC Designed Release Capsule.” https://www.capsugel.com/nutraceutical-solutions/hard-empty-capsules/hpmc-designed-release-capsule (accessed 2026-06-01).
8. “Roquette Showcases Expanded Consumer Healthcare Capabilities at Vitafoods.” Nutraceutical Business Review, 2026. https://nutraceuticalbusinessreview.com/roquette-showcases-its-expanded-consumer-healthcare-capabilities-at-vitafoods (accessed 2026-06-01).
9. “TopGum Unveils High-Dose Creatine and Electrolyte Gummies.” NutraIngredients, October 22, 2025. https://www.nutraingredients.com/Article/2025/10/22/topgum-unveils-high-dose-creatine-and-electrolyte-gummies/ (accessed 2026-06-01).
10. “Finalists of the Vitafoods Europe Innovation Awards 2026.” IngredientsNetwork, 2026. https://www.ingredientsnetwork.com/finalists-of-the-vitafoods-europe-innovation-news129187.html (accessed 2026-06-01).
11. Evonik. “EUDRAGUARD Portfolio.” https://healthcare.evonik.com/en/nutrition/supplement-coatings/eudraguard-portfolio (accessed 2026-06-01).
12. Colorcon. “Nutrateric Delayed-Release Coating.” https://www.colorcon.com/products/film-coatings/nutraceutical-dietary-supplement/nutrateric (accessed 2026-06-01).
13. EffePharm. “Products Powered by LipoAvail Liposomal Technology.” https://effepharm.com/our-products-category/products-powered-by-lipoavail-liposomal-technology/ (accessed 2026-06-01).
14. “Indena Unveils Advanced Botanical Solutions at Vitafoods.” Nutraceutical Business Review, 2026. https://nutraceuticalbusinessreview.com/indena-unveils-advanced-botanical-solutions-for-enhanced-healthy (accessed 2026-06-01).
15. “Lubrizol Launches Carbopol Polymers for Nutraceuticals with New EU Food-Grade Approval.” BusinessWire, October 23, 2023. https://www.businesswire.com/news/home/20231023177722/en/Lubrizol-Launches-Carbopol-Polymers-for-Nutraceuticals-with-New-EU-Food-Grade-Approval (accessed 2026-06-01).
16. Ashland. “Benecel Methylcellulose and Hypromellose for Dietary Supplements.” https://www.ashland.com/industries/pharmaceutical/dietary-supplements/benecel-methylcellulose-and-hypromellose (accessed 2026-06-01).
17. EVANIUM. “Optisolv Technology.” https://evanium.de/optisolv-technology/ (accessed 2026-06-01).
18. “Nourished Data Signals Surge in Demand for Sleep and Cognitive Support.” NutraIngredients, May 15, 2026. https://www.nutraingredients.com/Article/2026/05/15/nourished-data-signals-surge-in-demand-for-sleep-and-cognitive-support/ (accessed 2026-06-01).
19. “Balchem at Vitafoods 2026.” NutritionInsight, May 2026. https://www.nutritioninsight.com/video/balchem-sports-performance-vitafoods-2026.html (accessed 2026-06-01).
20. U.S. Food and Drug Administration. “New Dietary Ingredient (NDI) Notification Process.” https://www.fda.gov/food/dietary-supplements/new-dietary-ingredient-ndi-notification-process (accessed 2026-06-01).
21. European Food Safety Authority. “Nanotechnology.” https://www.efsa.europa.eu/en/topics/topic/nanotechnology (accessed 2026-06-01).

Ingredients insights. Straight to your inbox. Subscribe now.